Skip to main content

Find Clinical Trials

Home
Conditions
Encephalitis, Arbovirus

Clinical trial condition

Encephalitis, Arbovirus

Explore clinical trials studying Encephalitis, Arbovirus. Study availability and eligibility vary by location and protocol.

119 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Encephalitis, Arbovirus trial results

Completed

A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX

NCT00314145

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Chicago, Illinois, United States

Shawnee Mission, Kansas, United States

Missoula, Montana, United States

Dallas, Texas, United States

View Trial Details

Completed

Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.

NCT00314132

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Burbank, California, United States

Costa Mesa, California, United States

Davis, California, United States

San Francisco, California, United States

View all 22 locations

View Trial Details

Completed

Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine

NCT00981630

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Herston, Queensland, Australia

Adelaide, South Australia, Australia

View Trial Details

Completed

Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)

NCT00982137

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +19 more
Locations: Herston, Queensland, Australia

View Trial Details

Completed

Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age

NCT00441259

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Dr Atul's Child Hospital Jaipur, Rajasthan, India

Government Medical College Baroda, India

Maulana Azad Medical College New Delhi, India

View Trial Details

Completed

A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX

NCT00319592

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Clinical Pharamacology Center Lenexa, Kansas, United States

View Trial Details

Completed

A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults

NCT00981175

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Enoggera, Queensland, Australia

View Trial Details

Completed

This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population

NCT01158599

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Institut für Spezifische Prophylaxe und Tropenmedizin Vienna, State of Vienna, Austria

Medical University of Vienna - Klinische Pharmakologie Vienna, State of Vienna, Austria

Universitätsklinikum Hamburg-Eppendorf Hamburg, Free and Hanseatic City of Hamburg, Germany

Universitätsklinikum Rostock Rostock, Germany

View Trial Details

Completed

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

NCT01106482

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Winkelhoferstr. 3 Ehingen, Germany

Fuggerplatz 1 Kaufering, Germany

Hauptstrasse 240 Kehl, Germany

Bismarckstr. 3 Ludwigsburg, Germany

View Trial Details

Completed

Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis

NCT01386827

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Not specified

View Trial Details